Funder: GENCO PHARMA LLC
edit_calendar Duration: from 24 July 2016 to 23 July 2036 (240 months) Current
euro 0.00 EUR

Of International (non-EU) scope. It has been granted under a regime of Direct grant.

Call: (GENCO PHARMA LLC)

Researchers